EdgarLookup

CERO THERAPEUTICS HOLDINGS, INC. — All Filings

419 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFM14A DEFR14A DRS EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRER14A S-1 S-1/A S-3 S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-077436 Aug 15, 2025 Jun 30, 2025
EFFECT 9999999995-25-002650 Aug 15, 2025
SCHEDULE 13G/A 0001172661-25-003579 Aug 14, 2025
CORRESP 0001213900-25-076598 Aug 14, 2025
UPLOAD 0000000000-25-008554 Aug 14, 2025
S-3 REGISTRATION STATEMENT 0001213900-25-073849 Aug 11, 2025
EFFECT 9999999995-25-002395 Jul 29, 2025
S-8 REGISTRATION STATEMENT 0001213900-25-068283 Jul 28, 2025
CORRESP 0001213900-25-068215 Jul 28, 2025
UPLOAD 0000000000-25-007857 Jul 25, 2025
424B3 PROSPECTUS SUPPLEMENT 0001213900-25-067733 Jul 25, 2025
S-1 REGISTRATION STATEMENT 0001213900-25-066152 Jul 21, 2025
8-K CURRENT REPORT 0001213900-25-065655 Jul 18, 2025
424B3 424B3 0001213900-25-063764 Jul 14, 2025
8-K CURRENT REPORT 0001213900-25-063475 Jul 14, 2025 Jul 11, 2025
8-K CURRENT REPORT 0001213900-25-061911 Jul 8, 2025 Jul 7, 2025
424B3 PROSPECTUS SUPPLEMENT 0001213900-25-061023 Jul 2, 2025
8-K CURRENT REPORT 0001213900-25-059738 Jun 30, 2025 Jun 25, 2025
424B3 PROSPECTUS SUPPLEMENT NO. 3 0001213900-25-057780 Jun 25, 2025
8-K CURRENT REPORT 0001213900-25-054961 Jun 17, 2025
424B3 424B3 0001213900-25-054769 Jun 16, 2025
8-K CURRENT REPORT 0001213900-25-054371 Jun 13, 2025 Jun 11, 2025
8-K CURRENT REPORT 0001213900-25-053292 Jun 11, 2025
8-K CURRENT REPORT 0001213900-25-051750 Jun 6, 2025 Jun 5, 2025
424B3 PROSPECTUS SUPPLEMENT 0001213900-25-052185 Jun 6, 2025
4 0001213900-25-050116 Jun 2, 2025 May 30, 2025
8-K CURRENT REPORT 0001213900-25-050055 Jun 2, 2025 May 30, 2025
4 0001213900-25-050128 Jun 2, 2025 May 30, 2025
4 0001213900-25-050105 Jun 2, 2025 May 30, 2025
4 0001213900-25-050110 Jun 2, 2025 May 30, 2025
4 0001213900-25-050131 Jun 2, 2025 May 30, 2025
4 0001213900-25-050113 Jun 2, 2025 May 30, 2025
4 0001213900-25-050121 Jun 2, 2025 May 30, 2025
4 0001213900-25-050123 Jun 2, 2025 May 30, 2025
EFFECT 9999999995-25-001765 May 29, 2025
8-K CURRENT REPORT 0001213900-25-048998 May 29, 2025
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-25-047469 May 27, 2025
10-Q QUARTERLY REPORT 0001213900-25-044335 May 15, 2025 Mar 31, 2025
SCHEDULE 13G 0001172661-25-002215 May 15, 2025
3/A OWNERSHIP DOCUMENT 0001213900-25-040786 May 8, 2025 Oct 1, 2024
8-K CURRENT REPORT 0001213900-25-041063 May 8, 2025 May 7, 2025
DEF 14A PROXY STATEMENT 0001213900-25-040263 May 7, 2025 May 29, 2025
ARS ANNUAL REPORT 0001213900-25-040266 May 7, 2025 Dec 31, 2024
UPLOAD 0000000000-25-004807 May 7, 2025
D 0001470831-25-000015 May 6, 2025
PRER14A PROXY STATEMENT 0001213900-25-039149 May 2, 2025
CORRESP 0001213900-25-039151 May 2, 2025
UPLOAD 0000000000-25-004623 May 1, 2025
10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-25-036075 Apr 28, 2025 Dec 31, 2024
PRE 14A PROXY STATEMENT 0001213900-25-035562 Apr 25, 2025